Evolent Health, Inc. (EVH)
NYSE: EVH · Real-Time Price · USD
3.400
-0.150 (-4.23%)
Mar 5, 2026, 4:00 PM EST - Market closed
Evolent Health Analyst Ratings
Total Analysts
15
Consensus Rating
Strong Buy
Price Target
$7.93
Upside
+133.24%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Maintains $12 → $6 | Buy | Maintains | $12 → $6 | +76.47% | Mar 2, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $6 → $4 | Strong Buy | Maintains | $6 → $4 | +17.65% | Feb 26, 2026 |
| UBS | UBS | Strong Buy Maintains $10 → $5 | Strong Buy | Maintains | $10 → $5 | +47.06% | Feb 26, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $10 → $6 | Strong Buy | Maintains | $10 → $6 | +76.47% | Feb 26, 2026 |
| Needham | Needham | Strong Buy Maintains $15 → $4 | Strong Buy | Maintains | $15 → $4 | +17.65% | Feb 25, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $5 → $3 | Hold | Maintains | $5 → $3 | -11.76% | Feb 25, 2026 |
| Keybanc | Keybanc | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Feb 25, 2026 |
| BTIG | BTIG | Strong Buy Maintains $10 → $8 | Strong Buy | Maintains | $10 → $8 | +135.29% | Feb 25, 2026 |
| BTIG | BTIG | Strong Buy Maintains $16 → $10 | Strong Buy | Maintains | $16 → $10 | +194.12% | Feb 2, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $9.5 → $6 | Strong Buy | Maintains | $9.5 → $6 | +76.47% | Jan 9, 2026 |
| Citizens | Citizens | Buy Maintains $11 → $10 | Buy | Maintains | $11 → $10 | +194.12% | Jan 6, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $12 → $9.5 | Strong Buy | Maintains | $12 → $9.5 | +179.41% | Nov 21, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $13 → $7 | Buy | Maintains | $13 → $7 | +105.88% | Nov 17, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $16 → $9 | Strong Buy | Maintains | $16 → $9 | +164.71% | Nov 14, 2025 |
| BMO Capital | BMO Capital | Buy Initiates $7 | Buy | Initiates | $7 | +105.88% | Nov 13, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $18 → $12 | Buy | Maintains | $18 → $12 | +252.94% | Nov 12, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.